Detalhe da pesquisa
1.
Veterinary vaccine development from an industrial perspective.
Vet J
; 178(1): 7-20, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18313956
2.
Vaccine adjuvant technology: from theoretical mechanisms to practical approaches.
Dev Biol (Basel)
; 121: 127-34, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15962475
3.
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations.
Braz J Med Biol Res
; 45(8): 681-92, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22527130
4.
Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.
Anticancer Agents Med Chem
; 10(6): 462-70, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20879986
5.
Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.
Vaccine
; 27(33): 4439-46, 2009 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19500553
6.
Vaccine immunopotentiators of the future.
Clin Pharmacol Ther
; 82(6): 750-5, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17914440
7.
Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
Avian Pathol
; 36(1): 69-74, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17364512
8.
Human prophylactic vaccine adjuvants and their determinant role in new vaccine formulations
Braz. j. med. biol. res
; 45(8): 681-692, Aug. 2012. tab
Artigo
em Inglês
| LILACS | ID: lil-643654